Gallagher Fiduciary Advisors’s Pfizer PFE Stock Holding History

Gallagher Fiduciary Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$726K	Buy	30,148 +1,235	+4%	+$32.3K	0.02%	143
2026 Q1	$812K	Sell	28,913 -3,697	-11%	-$98.4K	0.03%	102
2025 Q4	$812K	Sell	32,610 -278	-0.8%	-$7.01K	0.03%	123
2025 Q3	$838K	Sell	32,888 -12,175	-27%	-$301K	0.03%	95
2025 Q2	$1.09M	Sell	45,063 -150	-0.3%	-$3.5K	0.04%	71
2025 Q1	$1.15M	Sell	45,213 -1,136	-2%	-$29.7K	0.04%	80
2024 Q4	$1.23M	Buy	46,349 +15,904	+52%	+$431K	0.24%	53
2024 Q3	$881K	Sell	30,445 -947	-3%	-$27.6K	0.18%	62
2024 Q2	$878K	Buy	31,392 +4,975	+19%	+$137K	0.2%	57
2024 Q1	$733K	Buy	26,417 +1,256	+5%	+$34.9K	0.03%	81
2023 Q4	$724K	Buy	25,161 +6,455	+35%	+$195K	0.02%	78
2023 Q3	$620K	Sell	18,706 -921	-5%	-$32.6K	0.05%	80
2023 Q2	$720K	Buy	19,627 +859	+5%	+$33.4K	0.05%	87
2023 Q1	$766K	Buy	+18,768	New	+$811K	0.06%	91
2015 Q2	–	Sell	-3,074,485	Closed	-$100M	–	5
2015 Q1	$100M	Sell	3,074,485 -374,342	-11%	-$11.9M	29.35%	2
2014 Q4	$102M	Buy	+3,448,827	New	+$98.9M	30.52%	3

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Gallagher Fiduciary Advisors's PFE Position: Q2 2026 in Review

Gallagher Fiduciary Advisors increased its Pfizer (PFE) stake by 4.3% in Q2 2026, buying an estimated $32.3K and bringing the position to 30,148 shares worth $726K. The position accounts for 0.02% of the portfolio, ranked #143.

Gallagher Fiduciary Advisors first reported a position in PFE in Q4 2014 and has held it in 16 quarters since. The position peaked at $102M in Q4 2014. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Gallagher Fiduciary Advisors held 30,148 shares of Pfizer worth $726K as of Q2 2026.
Gallagher Fiduciary Advisors bought 1,235 Pfizer shares in Q2 2026, an estimated $32.3K.
Pfizer made up 0.02% of Gallagher Fiduciary Advisors's portfolio in Q2 2026, its #143 holding.
Gallagher Fiduciary Advisors first reported a position in Pfizer in Q4 2014 and has held it in 16 quarters since.
Gallagher Fiduciary Advisors's Pfizer position peaked at $102M in Q4 2014.
2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Gallagher Fiduciary Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.